BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eisfeld HS, Simonis A, Winter S, Chhen J, Ströh LJ, Krey T, Koch M, Theobald SJ, Rybniker J. Viral Glycoproteins Induce NLRP3 Inflammasome Activation and Pyroptosis in Macrophages. Viruses 2021;13:2076. [PMID: 34696506 DOI: 10.3390/v13102076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Aggan HE, Mahmoud S, Deeb NE, Eleishi I, El-shendidi A. Significance of elevated serum and hepatic NOD-like receptor pyrin domain containing 3 (NLRP3) in hepatitis C virus-related liver disease. Sci Rep 2022;12:19528. [DOI: 10.1038/s41598-022-22022-5] [Reference Citation Analysis]
2 Wang H, Zhou X, Li C, Yan S, Feng C, He J, Li Z, Tu C. The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy. J Hematol Oncol 2022;15:140. [PMID: 36209102 DOI: 10.1186/s13045-022-01365-6] [Reference Citation Analysis]
3 Busch M, Bredeck G, Waag F, Rahimi K, Ramachandran H, Bessel T, Barcikowski S, Herrmann A, Rossi A, Schins RPF. Assessing the NLRP3 Inflammasome Activating Potential of a Large Panel of Micro- and Nanoplastics in THP-1 Cells. Biomolecules 2022;12:1095. [DOI: 10.3390/biom12081095] [Reference Citation Analysis]
4 Tang Y, Zhang P, Liu Q, Cao L, Xu J. Pyroptotic Patterns in Blood Leukocytes Predict Disease Severity and Outcome in COVID-19 Patients. Front Immunol 2022;13:888661. [DOI: 10.3389/fimmu.2022.888661] [Reference Citation Analysis]
5 Theobald SJ, Simonis A, Mudler JM, Göbel U, Acton R, Kohlhas V, Albert MC, Hellmann AM, Malin JJ, Winter S, Hallek M, Walczak H, Nguyen PH, Koch M, Rybniker J. Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination. EMBO Mol Med 2022;:e15888. [PMID: 35785445 DOI: 10.15252/emmm.202215888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 de Sá KS, Amaral LA, Caetano CC, Becerra A, Batah SS, de Oliveira IM, Lopes LS, Almeida L, Oliveira S, Wada DT, Koenigkam-santos M, Martins RB, Rosales RRC, Arruda E, Fabro AT, Zamboni DS. Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19.. [DOI: 10.1101/2022.06.24.22276878] [Reference Citation Analysis]
7 Wu L, Chen M, Li M, Wang Y, Li Y, Zheng L, Ke Z, Liu K, Qiao Y, Shi X. Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3/caspase-1/gasdermin D-induced inflammasome activation and hair cell pyroptosis. Mol Immunol 2022;149:66-76. [PMID: 35749835 DOI: 10.1016/j.molimm.2022.06.006] [Reference Citation Analysis]
8 Mukherjee A, Bagchi P. Special Issue: Host Cell–Virus Interaction. Viruses 2022;14:615. [DOI: 10.3390/v14030615] [Reference Citation Analysis]
9 Lage SL, Amaral EP, Hilligan KL, Laidlaw E, Rupert A, Namasivayan S, Rocco J, Galindo F, Kellogg A, Kumar P, Poon R, Wortmann GW, Shannon JP, Hickman HD, Lisco A, Manion M, Sher A, Sereti I. Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16- Monocytes From COVID-19 Patients. Front Immunol 2021;12:799558. [PMID: 35095880 DOI: 10.3389/fimmu.2021.799558] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]